Fibromyalgia Treatment Market to Reach USD 1,414.4 Million by 2027; Increasing Investments in R&D for Pain Management Therapies to Bolster Growth, states Fortune Business Insights™

Top Players Covered in the Fibromyalgia Treatment Market Research Report Are Pfizer, Inc. (U.S.), Eli Lilly and Company (U.S), Allergan (Ireland), Tonix Pharmaceuticals (U.S), Aptinyx (U.S), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Sun Pharmaceuticals (India), Astellas Pharma Inc (Japan) and other key market players.

Pune, India, March 09, 2021 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market size is expected to reach USD 1,414.4 million by 2027, exhibiting a CAGR of 9.2% during the forecast period. The heavy investments in R&D for the development of innovative drugs in pain management will subsequently boost the market growth, states Fortune Business Insights in a report, the market size stood at USD 1,918.1 million in 2019.

Increasing Healthcare Expenditure to Augment Growth in Asia Pacific

Asia Pacific is expected to dominate the fibromyalgia treatment market share during the forecast period. The large patient pool and increasing healthcare spending will enable speedy expansion of the market in the region. North America is expected to hold the largest share globally due to the growing prevalence of fibromyalgia.

Lack of treatment options for fibromyalgia and potential product launches is expected to augment the market's growth in Europe. Also, the growing healthcare expenditure by the European Commission is expected to propel the market in Europe.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/fibromyalgia-treatment-market-105016

Strong Pipeline Products to Augment Growth

The prominent companies are focused on introducing innovative therapies to improve their product portfolio in the market. Potential product launches and approvals by regulatory bodies to treat fibromyalgia can greatly impact the fibromyalgia treatment industry in the forthcoming years. For instance, in January 2021, Eli Lilly and Company developed Galcanezumab, which is currently under phase 4 clinical trial.

The drug has been approved for migraine and cluster headache; it is estimated to reach its pivotal clinical end-stage by December 2021 to treat fibromyalgia. Similarly, Teva Pharmaceuticals’ AJOVY is approved in the U.S for migraines and is currently under phase 2 clinical trial to manage fibromyalgia.

The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/fibromyalgia-treatment-market-105016

Lower Frequency of Patients Availing Treatment to Dampen Fibromyalgia Treatment Market Growth amid COVID-19

The COVID-19 outbreak has negatively impacted the global market across the globe. The surging cases of coronavirus have led to the high proclivity towards coronavirus vaccination in the pharmaceutical industry. Moreover, the lower frequency rate of patients availing treatment for fibromyalgia coupled with underdiagnosed indication, will restrict the market growth amid coronavirus.

Besides, the increasing production of COVID-19 medicine and preventative vaccines is expected to disrupt fibromyalgia treatment drugs' supply and demand during the pandemic.

Quick Buy - Fibromyalgia Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105016

The Report Lists the Key Players in this Market:

• • Pfizer, Inc. (U.S.)

  • Eli Lilly and Company (U.S)

  • Allergan (Ireland)

  • Tonix Pharmaceuticals (U.S)

  • Aptinyx (U.S)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Novartis AG (Switzerland)

  • Sun Pharmaceuticals (India)

  • Astellas Pharma Inc (Japan)

  • Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/fibromyalgia-treatment-market-105016

Some major points from Table of Content:

• Introduction

  • Research Scope

  • Market Segmentation

  • Research Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Prevalence of Fibromyalgia by key Regions

  • Key Industry Trends

  • Pipeline Analysis

  • Regulatory Scenario

  • Recent Industry Developments Such as Mergers & Acquisitions

  • Impact of COVID-19 on the Market

• Global Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Drug Class

    • Antidepressants

    • Antiepileptic

    • Muscle Relaxants

    • Others

  • Market Analysis, Insights and Forecast – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

  • Market Analysis, Insights and Forecast – By Country

    • North America

    • Europe

    • Asia pacific

    • Latin America

    • Middle East & Africa

• North America Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027

  • Key Findings / Summary

  • Market Analysis – By Drug Class

    • Antidepressants

    • Antiepileptic

    • Muscle Relaxants

    • Others

  • Market Analysis – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

  • Market Analysis – By Country

    • U.S.

      • By Drug Class

        • Antidepressants

        • Antiepileptic

        • Muscle Relaxants

        • Others

    • Canada

      • By Drug Class

        • Antidepressants

        • Antiepileptic

        • Muscle Relaxants

        • Others

Continued...

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/fibromyalgia-treatment-market-105016

Have a Look at Related Reports:

Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026

Bone Growth Stimulator Market Size, Share and Industry Analysis By Product Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)), By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and Regional Forecast 2019-2026

Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

Population Health Management (PHM) Market Size, Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast, 2019-2026

Germany Smart Healthcare Market Size, Share & COVID-19 Impact Analysis, By Product (Electronic Health Record, Smart Medication Delivery, Telemedicine, RFID Systems, mHealth, and Others), By Application (Health Data Storage, Monitoring and Treatment, Inventory Management, and Others), and by End User (Hospitals & ASCs, Homecare Settings, and Others) and Forecast, 2020-2027

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-fibromyalgia-treatment-market-10542